Reagena
Toivala
About Reagena
Reagena is a chemistry company with development, manufacturing, and sales of internationally proven, high quality products in two business segments: Infectious disease diagnostics and liquid based solutions and reagents for life sciences. Reagena is committed to the development of novel innovative diagnostics such as rapid point-of-care (POC) tests for the determination of chemokine CXCL13, acute Hantavirus infections as well as tick-borne encephalitis (TBE) virus diagnostics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $56.0K
- Last round: Grant (May 2015)
- Website: reagena.comen
- Phone: [email protected]
Industries & Categories
Manufacturing, Medical, Sales
Social Profiles
Canonical: https://fsome.com/organization/reagena-3487691 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.